Journal
CURRENT OPINION IN ONCOLOGY
Volume 13, Issue 5, Pages 399-402Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001622-200109000-00015
Keywords
-
Categories
Ask authors/readers for more resources
Given the burden of suffering associated with the development of ovarian cancer and the clear survival gradient related to the stage of disease at diagnosis, there is much enthusiasm for the development of effective screening strategies aimed at early detection. To date, no evidence exists to justify mass population screening; however, emphasis on subpopulation screening, identification of novel serologic markers, and multimodality screening designs have provided hope that these refinements may eventually translate into a reduction in ovarian cancer mortality. Curr Opin Oncol 2001, 13:399-402 (C) 2001 Lippincott Williams & Wilkins, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available